The genetics of splicing in neuroblastoma.

UNLABELLED Regulation of mRNA splicing, a critical and tightly regulated cellular function, underlies the majority of proteomic diversity and is frequently disrupted in disease. Using an integrative genomics approach, we combined both genomic data and exon-level transcriptome data in two somatic tissues (cerebella and peripheral ganglia) from a transgenic mouse model of neuroblastoma, a tumor that arises from the peripheral neural crest. Here, we describe splicing quantitative trait loci associated with differential splicing across the genome that we use to identify genes with previously unknown functions within the splicing pathway and to define de novo intronic splicing motifs that influence splicing from hundreds of bases away. Our results show that these splicing motifs represent sites for functional recurrent mutations and highlight novel candidate genes in human cancers, including childhood neuroblastoma. SIGNIFICANCE Somatic mutations with predictable downstream effects are largely relegated to coding regions, which comprise less than 2% of the human genome. Using an unbiased in vivo analysis of a mouse model of neuroblastoma, we have identified intronic splicing motifs that translate into sites for recurrent somatic mutations in human cancers.

[1]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[2]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[3]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[4]  Zefeng Wang,et al.  Intronic Splicing Enhancers, Cognate Splicing Factors and Context Dependent Regulation Rules , 2012, Nature Structural &Molecular Biology.

[5]  Joseph K. Pickrell,et al.  Understanding mechanisms underlying human gene expression variation with RNA sequencing , 2010, Nature.

[6]  L. Liotta,et al.  A Transforming Growth Factor-β Receptor–Interacting Protein Frequently Mutated in Human Ovarian Cancer , 2005 .

[7]  M. Garcia-Blanco,et al.  Alternative splicing in disease and therapy , 2004, Nature Biotechnology.

[8]  Mark I. McCarthy,et al.  Identification of an imprinted master trans-regulator at the KLF14 locus related to multiple metabolic phenotypes , 2011, Nature Genetics.

[9]  Thomas M. Keane,et al.  Sequencing and characterization of the FVB/NJ mouse genome , 2012, Genome Biology.

[10]  D. Zwijnenburg,et al.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes , 2012, Nature.

[11]  Jacek Majewski,et al.  Genome-wide analysis of transcript isoform variation in humans , 2008, Nature Genetics.

[12]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[13]  J. Valcárcel,et al.  The spliceosome as a target of novel antitumour drugs , 2012, Nature Reviews Drug Discovery.

[14]  H. Fraser,et al.  Common polymorphic transcript variation in human disease. , 2009, Genome research.

[15]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[16]  Frequent Pathway Mutations of Splicing Machinery in Myelodysplasia , 2011 .

[17]  Hiroki Nagase,et al.  Genetic architecture of murine skin inflammation and tumor susceptibility , 2016 .

[18]  Rolf Backofen,et al.  Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity , 2004, Nature Genetics.

[19]  Tatiana Popova,et al.  Supplementary Methods , 2012, Acta Neuropsychiatrica.

[20]  Brendan J. Frey,et al.  A compendium of RNA-binding motifs for decoding gene regulation , 2013, Nature.

[21]  G. Clore,et al.  Structure and dynamics of KH domains from FBP bound to single-stranded DNA , 2002, Nature.

[22]  J. Khan,et al.  Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status , 2011, BMC Medical Genomics.

[23]  Jinghui Zhang,et al.  Association of age at diagnosis and genetic mutations in patients with neuroblastoma. , 2012, JAMA.

[24]  L. Liotta,et al.  A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer. , 2005, Cancer research.

[25]  A. Inoue,et al.  RBM10 regulates alternative splicing , 2014, FEBS letters.

[26]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Chen,et al.  Alternative splicing in cancer: implications for biology and therapy , 2014, Oncogene.

[28]  Mikael Bodén,et al.  MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..

[29]  K. Shianna,et al.  Tissue-Specific Genetic Control of Splicing: Implications for the Study of Complex Traits , 2008, PLoS biology.

[30]  M. Schwab,et al.  Suppression of MYC by high expression of NMYC in human neuroblastoma cells , 1989, Journal of neuroscience research.

[31]  Antonio Ortega,et al.  Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. , 2006, Journal of the National Cancer Institute.

[32]  D. Koller,et al.  Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals , 2013, Genome research.

[33]  P. Schirmacher,et al.  Overexpression of far upstream element binding proteins: A mechanism regulating proliferation and migration in liver cancer cells , 2009, Hepatology.

[34]  A. Look,et al.  Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group , 2013, Cancer.

[35]  Henning Urlaub,et al.  Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD‐box protein , 2002, The EMBO journal.

[36]  C. Gissi,et al.  Assessment of orthologous splicing isoforms in human and mouse orthologous genes , 2010, BMC Genomics.

[37]  J. Doudna,et al.  Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma , 2011 .

[38]  H. Hakonarson,et al.  Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. , 2012, Cancer research.

[39]  P. Cahan,et al.  Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression. , 2011, The Journal of clinical investigation.

[40]  J. Buizer-Voskamp,et al.  Recurrent CNVs disrupt three candidate genes in schizophrenia patients. , 2008, American journal of human genetics.

[41]  Chandra Sekhar Pedamallu,et al.  A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events , 2014, PloS one.

[42]  Steven P. Gygi,et al.  Comprehensive proteomic analysis of the human spliceosome , 2002, Nature.

[43]  William A Weiss,et al.  Neuroblastoma and MYCN. , 2013, Cold Spring Harbor perspectives in medicine.

[44]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[45]  J. Uhm Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .

[46]  L. Kruglyak,et al.  Genetic Dissection of Transcriptional Regulation in Budding Yeast , 2002, Science.

[47]  Nikolaus Grigorieff,et al.  Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. , 2002, RNA.

[48]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[49]  R. Guigó,et al.  Transcriptome genetics using second generation sequencing in a Caucasian population , 2010, Nature.

[50]  G. Mohapatra,et al.  Targeted expression of MYCN causes neuroblastoma in transgenic mice , 1997, The EMBO journal.

[51]  K. M. Mulder,et al.  A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein. , 2002, Molecular biology of the cell.

[52]  N. Awasthi,et al.  Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II , 2012, PloS one.

[53]  D. Levens,et al.  A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. , 1994, Genes & development.

[54]  Christopher B. Burge,et al.  Alternative Splicing of RNA Triplets Is Often Regulated and Accelerates Proteome Evolution , 2012, PLoS biology.

[55]  David Levens,et al.  FBPs Are Calibrated Molecular Tools To Adjust Gene Expression , 2006, Molecular and Cellular Biology.

[56]  Harry Zuzan,et al.  Heritability of alternative splicing in the human genome. , 2007, Genome research.